Structural and functional analysis of missense mutations in fumarylacetoacetate hydrolase, the gene deficient in hereditary tyrosinemia type 1

被引:33
作者
Bergeron, A
D'Astous, M
Timm, DE
Tanguay, RM
机构
[1] Univ Laval, Dept Med, Lab Cell & Dev Genet, St Foy, PQ G1K 7P4, Canada
[2] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA
关键词
D O I
10.1074/jbc.M009341200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hereditary tyrosinemia type 1 (HT1) is an autosomal recessive disease caused by a deficiency of the enzyme involved in the last step of tyrosine degradation, fumarylacetoacetate hydrolase (FAH), Thus far, 34 mutations in the FAH gene have been reported in various HT1 patients. Site-directed mutagenesis of the FAH cDNA was used to investigate the effects of eight missense mutations found in HTI patients on the structure and activity of FAH, Mutated FAH proteins were expressed in Escherichia coli and in mammalian CV 1 cells. Mutations N16I, F62C, A134D, C193R, D233V, and W234G lead to enzymatically inactive FAH proteins. Two mutations (R341W, associated with the pseudo-deficiency phenotype, and Q279R) produced proteins with a level of activity comparable to the wild-type enzyme. The N16I, F62C, C193R, and W234G variants were enriched in an insoluble cellular fraction, suggesting that these amino acid substitutions interfere with the proper folding of the enzyme. Based on the tertiary structure of FAH, on circular dichroism data, and on solubility measurements, we propose that the studied missense mutations cause three types of structural effects on the enzyme: 1) gross structural perturbations, 2) limited conformational changes in the active site, and 3) conformational modifications with no significant effect on enzymatic activity.
引用
收藏
页码:15225 / 15231
页数:7
相关论文
共 34 条
[1]   STRUCTURAL ORGANIZATION AND ANALYSIS OF THE HUMAN FUMARYLACETOACETATE HYDROLASE GENE IN TYROSINEMIA TYPE-I [J].
AWATA, H ;
ENDO, F ;
TANOUE, A ;
KITANO, A ;
NAKANO, Y ;
MATSUDA, I .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1994, 1226 (02) :168-172
[2]   TYPE-I TYROSINEMIA - LACK OF IMMUNOLOGICALLY DETECTABLE FUMARYLACETOACETASE ENZYME PROTEIN IN TISSUES AND CELL-EXTRACTS [J].
BERGER, R ;
VANFAASSEN, H ;
TAANMAN, JW ;
DEVRIES, H ;
AGSTERIBBE, E .
PEDIATRIC RESEARCH, 1987, 22 (04) :394-398
[3]  
Bergman AJIW, 1998, HUM MUTAT, V12, P19, DOI 10.1002/(SICI)1098-1004(1998)12:1<19::AID-HUMU3>3.3.CO
[4]  
2-V
[5]   An Escherichia coli host strain useful for efficient overproduction of cloned gene products with NaCl as the inducer [J].
Bhandari, P ;
Gowrishankar, J .
JOURNAL OF BACTERIOLOGY, 1997, 179 (13) :4403-4406
[6]  
DEBRAEKELEER M, 1990, AM J HUM GENET, V47, P302
[7]   SINGLE MUTATION OF THE FUMARYLACETOACETATE HYDROLASE GENE IN FRENCH-CANADIANS WITH HEREDITARY TYROSINEMIA TYPE-I [J].
GROMPE, M ;
STLOUIS, M ;
DEMERS, SI ;
ALDHALIMY, M ;
LECLERC, B ;
TANGUAY, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (06) :353-357
[8]   HETEROZYGOSITY FOR AN EXON-12 SPLICING MUTATION AND A W234G MISSENSE MUTATION IN AN AMERICAN CHILD WITH CHRONIC TYROSINEMIA TYPE-1 [J].
HAHN, SH ;
KRASNEWICH, D ;
BRANTLY, M ;
KVITTINGEN, EA ;
GAHL, WA .
HUMAN MUTATION, 1995, 6 (01) :66-73
[9]   PURIFICATION AND PROPERTIES OF A DIKETO ACID HYDROLASE FROM BEEF LIVER [J].
HSIANG, HH ;
SCHMIDT, DE ;
SIM, SS ;
MAHURAN, DJ .
BIOCHEMISTRY, 1972, 11 (11) :2098-&
[10]  
JOHNSON CW, 1990, PROTEIN-STRUCT FUNCT, V7, P205